%20PLC/other/GRAFT_POLYMER_UK_PLC-logo.png)
GRAFT POLYMER (UK) PLC
GPL | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMD1Z199
- LEI:
- 2138005PH7OJRCRPUD88
- Country:
- United Kingdom
- Address:
- Eccleston Yards, SW1W 9NF London
- Website:
- https://graftpolymer.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of basic chemicals, fertilizers and nitrogen compounds, plastics and synthetic rubber in primary forms
Description
Graft Polymer is an innovative materials technology company specializing in polymer modification and the development of drug delivery systems. Its core business revolves around proprietary methods to combine incompatible polymers, creating high-performance alloys and compounds with enhanced mechanical, chemical, and fire-retardant properties. The company provides bespoke, "turn-key" solutions and customized products based on client requirements. Through its GraftBio division, launched in 2020, the company also develops intellectual property for bio/pharma applications, including biological supplements and advanced biopolymer drug delivery systems designed to improve the efficacy of therapeutics. The Group holds strong intellectual property and has filed several patent applications for its technologies.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for GRAFT POLYMER (UK) PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-13 16:03 |
Regulatory News Service
Media Coverage: Small Cap Idea profile
|
English | 10.8 KB | |
2025-08-12 08:00 |
Regulatory News Service
SVN-SDN-14 PTSD - Positive pre-clinical results
|
English | 11.3 KB | |
2025-07-31 17:30 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 9.9 KB | |
2025-07-22 08:00 |
Regulatory News Service
Translational Bridging Studies
|
English | 11.8 KB | |
2025-07-18 12:03 |
Share Issue/Capital Change
Exercise of warrants
|
English | 9.0 KB | |
2025-07-11 08:00 |
Share Issue/Capital Change
£1m subscription to accelerate AI drug discovery
|
English | 12.5 KB | |
2025-06-27 15:38 |
Post-Annual General Meeting Information
AGM Statement
|
English | 22.1 KB | |
2025-06-27 09:54 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.8 KB | |
2025-06-26 11:21 |
Regulatory News Service
Initiation of Research Coverage
|
English | 10.4 KB | |
2025-06-23 08:00 |
Regulatory News Service
Allowance of U.S. patent covering AI-supported CNS
|
English | 10.8 KB | |
2025-06-11 08:30 |
Business and Financial Review
Initiation of AI supported CNS drug discovery
|
English | 10.8 KB | |
2025-06-05 08:00 |
Environmental & Social Information
Synthesis of development candidate for SVN-SDN-014
|
English | 11.2 KB | |
2025-06-03 17:35 |
Proxy Solicitation & Information Statement
Proxy form for Annual General Meeting 2025
|
English | 144.3 KB | |
2025-06-03 17:34 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting
|
English | 138.4 KB | |
2025-06-03 17:30 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting
|
English | 9.7 KB |
Automate Your Workflow. Get a real-time feed of all GRAFT POLYMER (UK) PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for GRAFT POLYMER (UK) PLC via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
Specialist in PEEK & PAEK high-performance polymers for challenging engineering applications.
|
United Kingdom | VCT |